Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MBX Biosciences, Inc. (MBX)
NASDAQ:MBX
RESEARCH TOOLSreports
Holding MBX?
Track your performance easily
MBX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$15.57 - $27.50
Previous Close$15.94
Volume166.66K
Average Volume (3M)156.45K
Market Cap
$532.67M
Enterprise Value$477.66M
Total Cash (Recent Filing)$55.26M
Total Debt (Recent Filing)$249.00K
Price to Earnings (P/E)―
Beta2.33
Next Earnings
Nov 07, 2024EPS Estimate
-$2.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding33,417,418
10 Day Avg. Volume98,737
30 Day Avg. Volume156,454
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-17.01
Forecast
1Y Price Target
$37.25Price Target Upside129.37% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
MBX Biosciences, Inc. News
PremiumCompany Announcements
MBX Biosciences Reports Q3 2024 Financial Progress
MBX FAQ
What was MBX Biosciences, Inc.’s price range in the past 12 months?
MBX Biosciences, Inc. lowest stock price was $15.57 and its highest was $27.50 in the past 12 months.
What is MBX Biosciences, Inc.’s market cap?
Currently, no data Available
When is MBX Biosciences, Inc.’s upcoming earnings report date?
MBX Biosciences, Inc.’s upcoming earnings report date is Nov 07, 2024 which is 14 days ago.
How were MBX Biosciences, Inc.’s earnings last quarter?
Currently, no data Available
Is MBX Biosciences, Inc. overvalued?
According to Wall Street analysts MBX Biosciences, Inc.’s price is currently Undervalued.
Does MBX Biosciences, Inc. pay dividends?
MBX Biosciences, Inc. does not currently pay dividends.
What is MBX Biosciences, Inc.’s EPS estimate?
MBX Biosciences, Inc.’s EPS estimate is -$2.72.
How many shares outstanding does MBX Biosciences, Inc. have?
MBX Biosciences, Inc. has 33,417,420 shares outstanding.
What happened to MBX Biosciences, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MBX Biosciences, Inc.?
Currently, no hedge funds are holding shares in MBX
---
MBX Biosciences, Inc. Stock Smart Score
Company Description
MBX Biosciences, Inc.
MBX Biosciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. Our PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. We are advancing a pipeline of novel candidates for endocrine and metabolic disorders. Our lead product candidate, MBX 2109, is a parathyroid hormone peptide prodrug that is designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism, or HP. We designed MBX 2109 to treat the underlying pathophysiology of HP by providing a continuous, infusion-like exposure to parathyroid hormone, or PTH, with convenient once-weekly administration.
---
MBX Stock 12 Month Forecast
Average Price Target
$37.25
▲(129.37% Upside)
Technical Analysis
Alnylam Pharma
―
Vertex Pharmaceuticals
―
Arrowhead Pharmaceuticals
―
Sarepta Therapeutics
―
Best Analysts Covering MBX
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+3.90%
initiated a buy rating last month
Copying Seamus Fernandez's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +3.90% per trade.
---